# ClinicalTrials.gov record NCT03770338

> PeptideScanner retained ClinicalTrials.gov record NCT03770338 at 2026-07-30T16:19:36.903Z. Its registry update date was 2026-05-14, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct03770338-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-05-14
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03770338-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03770338-teriparatide-v1.json
- Content SHA-256: `075090e102c17980e0c17d2a99a0e55de4fb1a55c354ad7b4defee436f9cf7f0`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT03770338 ([`ctg-observation-nct03770338-2026-05-14-9e3e9c86e03a`](#source-ctg-observation-nct03770338-2026-05-14-9e3e9c86e03a))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03770338 at 2026-07-30T16:19:36.903Z. Its registry update date was 2026-05-14, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct03770338-2026-05-14-9e3e9c86e03a`](#source-ctg-observation-nct03770338-2026-05-14-9e3e9c86e03a))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03770338 at 2026-07-30T16:19:36.903Z. Its registry update date was 2026-05-14, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct03770338-2026-05-14-9e3e9c86e03a`](#source-ctg-observation-nct03770338-2026-05-14-9e3e9c86e03a))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03770338-2026-05-14-9e3e9c86e03a`](#source-ctg-observation-nct03770338-2026-05-14-9e3e9c86e03a))

## Sources

<a id="source-ctg-observation-nct03770338-2026-05-14-9e3e9c86e03a"></a>
- **ClinicalTrials.gov record NCT03770338 · retained source version 2026-05-14:9e3e9c86e03a720b0dc21c99a674219a136d6aad17c901a70610f2d972db3a8c** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03770338) (`ctg-observation-nct03770338-2026-05-14-9e3e9c86e03a`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03770338." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03770338-teriparatide-v1.json SHA-256: 075090e102c17980e0c17d2a99a0e55de4fb1a55c354ad7b4defee436f9cf7f0.